13 min
Assessing the Safety of Cellulosic Nanomaterials: A Conversation with Jo Anne Shatkin Stories from the NNI
-
- Science
In this episode of the “Stories from the NNI” podcast, Dr. Jo Anne Shatkin, President and Founder of Vireo Advisors, discusses how her company is leading efforts to assess the safety of cellulosic nanomaterials.
If you would like to learn more about nanotechnology, go to nano.gov or email us at info@nnco.nano.gov.
Closed captioning is provided on our YouTube channel. For this episode, go to: https://youtu.be/ioD-9Kq5YpU
CREDITS
Special thanks to:
Jo Anne Shatkin
Vireo Advisors
Produced by:
Andrew Pomeroy
Music:
Inspirational Outlook by Scott Holmes
https://freemusicarchive.org/music/Sc...
https://creativecommons.org/licenses/...
Any opinions, findings, conclusions, or recommendations expressed in this podcast are those of the guest and do not necessarily reflect the views of the National Nanotechnology Coordination Office or United States Government. Additionally, mention of trade names or commercial products does not constitute endorsement or recommendation by any of the aforementioned parties. Any mention of commercial products, processes, or services cannot be construed as an endorsement or recommendation.
In this episode of the “Stories from the NNI” podcast, Dr. Jo Anne Shatkin, President and Founder of Vireo Advisors, discusses how her company is leading efforts to assess the safety of cellulosic nanomaterials.
If you would like to learn more about nanotechnology, go to nano.gov or email us at info@nnco.nano.gov.
Closed captioning is provided on our YouTube channel. For this episode, go to: https://youtu.be/ioD-9Kq5YpU
CREDITS
Special thanks to:
Jo Anne Shatkin
Vireo Advisors
Produced by:
Andrew Pomeroy
Music:
Inspirational Outlook by Scott Holmes
https://freemusicarchive.org/music/Sc...
https://creativecommons.org/licenses/...
Any opinions, findings, conclusions, or recommendations expressed in this podcast are those of the guest and do not necessarily reflect the views of the National Nanotechnology Coordination Office or United States Government. Additionally, mention of trade names or commercial products does not constitute endorsement or recommendation by any of the aforementioned parties. Any mention of commercial products, processes, or services cannot be construed as an endorsement or recommendation.
13 min